Covered recipient · General Payments record
MELISSA A CETAK
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2024
$5,002.84
- Reported across 256 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,137.94 | 67 |
| Education | $197.95 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $279.72 | 10 |
| ABBVIE INC. | $134.79 | 9 |
| EISAI INC. | $131.71 | 5 |
| PFIZER INC. | $107.54 | 9 |
| SANOFI-AVENTIS U.S. LLC | $98.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $90.78 | 5 |
| SERVIER PHARMACEUTICALS LLC | $41.07 | 2 |
| Acerta Pharma LLC | $39.53 | 2 |
| Ipsen Biopharmaceuticals, Inc | $32.58 | 2 |
| E.R. Squibb & Sons, L.L.C. | $32.22 | 2 |
| PharmaEssentia USA Corporation | $30.38 | 2 |
| Gilead Sciences, Inc. | $29.69 | 2 |
| Merck Sharp & Dohme Corporation | $29.36 | 2 |
| ARRAY BIOPHARMA INC | $25.88 | 2 |
| Genmab U.S., Inc. | $23.28 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.23 | 1 |
| Astellas Pharma US Inc | $18.03 | 1 |
| AVEO Pharmaceuticals, Inc. | $17.92 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $17.20 | 1 |
| Stemline Therapeutics Inc. | $17.07 | 1 |
| Exelixis Inc. | $16.73 | 1 |
| Daiichi Sankyo Inc. | $15.90 | 1 |
| Genentech USA, Inc. | $15.24 | 1 |
| Regeneron Healthcare Solutions, Inc. | $14.96 | 1 |
| SOBI, INC | $14.41 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $14.38 | 1 |
| TAIHO ONCOLOGY, INC. | $14.37 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $13.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (69)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.